Only four genes differentially expressed in both LGG and GBM patients (ERBB1, RB1, ESR1, and KDR), indicating putative role in the regulatory of circadian rhythm pathway alteration in glioma. The gene discussed is EGFR; the disease is central nervous system cancer.